Michael M. Im
Impact in
- Internal Medicine top 5%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- DNA Repair Mechanisms 7
- Mitochondrial Function and Pathology 4
- Photosynthetic Processes and Mechanisms 4
- Biochemical and Molecular Research 2
- RNA modifications and cancer 2
- Oncology 5
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 2
- Co-authors
- Donna S. Shewach (10 shared papers)Assaf C. Bester (2 shared papers)Batsheva Kerem (2 shared papers)Gideon A. Zamir (1 shared paper)Aaron Bensimon (1 shared paper)Yifat S. Oren (1 shared paper)Dan Sarni (1 shared paper)Maayan Roniger (1 shared paper)
- Journals
- Biochemistry (4 papers)Radiation Research (2 papers)Blood (1 paper)Cell (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- United StatesIsraelRussia
In The Last Decade
Michael M. Im
17 papers receiving 1.6k citations
Michael M. Im's Hit Papers
Peers
Comparison fields: 5 of 93
- Internal Medicine 75
- Cancer Research 265
- Hematology 175
- Molecular Biology 1.1k
- Oncology 323
Countries citing papers authored by Michael M. Im
This map shows the geographic impact of Michael M. Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Im more than expected).
Fields of papers citing papers by Michael M. Im
This network shows the impact of papers produced by Michael M. Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Im. The network helps show where Michael M. Im may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael M. Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development Hit paper breakdown → | 2011 | 674 |
| 2 | 2004 | 244 | |
| 3 | 2008 | 206 | |
| 4 | 2012 | 70 | |
| 5 | 2006 | 56 | |
| 6 | 2003 | 55 | |
| 7 | Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. | 2003 | 48 |
| 8 | 2013 | 48 | |
| 9 | 2002 | 38 | |
| 10 | 2002 | 36 | |
| 11 | 2004 | 34 | |
| 12 | 2003 | 31 | |
| 13 | 2015 | 29 | |
| 14 | 2006 | 29 | |
| 15 | 2016 | 12 | |
| 16 | 2015 | 7 | |
| 17 | 2016 | 5 |
About Michael M. Im
Michael M. Im is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Internal Medicine, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), Mitochondrial Function and Pathology (4 papers), Photosynthetic Processes and Mechanisms (4 papers), Plant Stress Responses and Tolerance (3 papers), Cancer-related Molecular Pathways (3 papers), Biochemical and Molecular Research (2 papers), PARP inhibition in cancer therapy (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Internal Medicine (75 citations), Cancer Research (265 citations), Hematology (175 citations), Molecular Biology (1.1k citations) and Oncology (323 citations). Michael M. Im has collaborated with scholars based in United States, Israel and Russia. Frequent co-authors include Donna S. Shewach, Assaf C. Bester, Batsheva Kerem, Gideon A. Zamir, Aaron Bensimon, Yifat S. Oren, Dan Sarni, Maayan Roniger, William P. Fay and Charles F. Yocum. Their work appears in journals such as Biochemistry, Radiation Research, Blood, Cell and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.